The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 01, 2026
Filed:
Nov. 01, 2022
High Performance Optics, Inc., Roanoke, VA (US);
Mark Acerson, North Logan, UT (US);
David Owen Baumann, Hyrum, UT (US);
Dustin Cefalo, Logan, UT (US);
Frank Chang, Cumming, GA (US);
Peter Haaland, Belmont, MA (US);
Troy Holland, Suwanee, GA (US);
Andrew Ishak, Aberdeen, MD (US);
Raja Gabadage Waruna E. Jinadasa, North Logan, UT (US);
Mark L. Nelson, Midway, UT (US);
Larry Rodriguez, Concord, NC (US);
Adam Sniady, Lilburn, GA (US);
Houliang Tang, Alpharetta, GA (US);
Jiangxing Zhang, Salt Lake City, UT (US);
High Performance Optics, Inc., Roanoke, VA (US);
Abstract
The present disclosure provides metalloporphyrin and metallochlorin compounds (e.g., compounds of Formula (II) and (III)), which are useful in the preparation of optical devices (e.g., contact lenses, intraocular lenses, implantable contact lenses) that protect retinal pigment epithelium by the selective blocking of blue light. Also provided are precursor porphyrin and chlorin compounds (e.g., compounds of Formula (I)), and compositions and optical devices incorporating the compounds of the disclosure. Also provided are methods of selecting appropriate metalloporphyrin and metallochlorin compounds for incorporation into optical devices wherein the devices mitigate damage to retinal epithelial cells while balancing changes to luminous transmission, discomfort glare, color distortion, and disruption of circadian rhythms.